|
VPS35 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.196000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.528420E-01 |
| Normal-vs-Stage2 |
1.877990E-01 |
| Normal-vs-Stage3 |
2.608500E-02 |
| Normal-vs-Stage4 |
8.990800E-01 |
| Stage1-vs-Stage2 |
6.042800E-01 |
| Stage1-vs-Stage3 |
1.794770E-01 |
| Stage1-vs-Stage4 |
3.652800E-01 |
| Stage2-vs-Stage3 |
5.544000E-01 |
| Stage2-vs-Stage4 |
3.214600E-01 |
| Stage3-vs-Stage4 |
1.453620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.800170E-02 |
| Normal-vs-AfricanAmerican |
2.131200E-01 |
| Normal-vs-Asian |
5.835400E-01 |
| Caucasian-vs-AfricanAmerican |
6.533800E-01 |
| Caucasian-vs-Asian |
9.926400E-01 |
| AfricanAmerican-vs-Asian |
8.516000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.356000E-01 |
| Normal-vs-Female |
1.416640E-04 |
| Male-vs-Female |
5.396000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.083400E-01 |
| Normal-vs-Extreme_Weight |
7.964600E-01 |
| Normal-vs-Obese |
4.129900E-02 |
| Normal-vs-Extreme_Obese |
5.340400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.849600E-01 |
| Normal_Weight-vs-Obese |
1.941970E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.039200E-01 |
| Extreme_Weight-vs-Obese |
4.187700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.106000E-01 |
| Obese-vs-Extreme_Obese |
8.273800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.405980E-01 |
| Normal-vs-Age(41-60Yrs) |
1.291940E-02 |
| Normal-vs-Age(61-80Yrs) |
1.718220E-01 |
| Normal-vs-Age(81-100Yrs) |
9.730600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.807000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.062400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.405200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.022200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.368600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.425000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.248000E-01 |
| Normal-VS-Type2 PRCC |
1.744220E-02 |
| Normal-VS-KIRP CIMP |
6.325900E-02 |
| Normal-VS-Unclassified PRCC |
1.144280E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.894300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.622100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.459700E-03 |
| Type2 PRCC-VS-KIRP CIMP |
3.202800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.133600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.621200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.836800E-01 |
| Normal-vs-N1 |
1.671590E-02 |
| Normal-vs-N2 |
7.221600E-01 |
| N0-vs-N1 |
6.440500E-02 |
| N0-vs-N2 |
6.936400E-01 |
| N1-vs-N2 |
2.004800E-01 |
|
|
